Background: Anti third-party cytotoxic T lymphocytes (CTLs) were shown to exhibit marked veto activity, thereby inducing transplantation tolerance across major histocompatibility antigens. Elimination of effector cells requires co-expression of CD8 and FasL on the veto cells and is mediated through CD8-major histocompatibility complex (MHC) class I interaction and Fas-Fas ligand signaling.

Methods: To further interrogate the signaling events induced in the effector cells on their interaction with veto cell populations, effector cells from 2C transgenic mice were preincubated with different signaling inhibitors and were subject to fluorescence-activated cell sorting and western blot analysis.

Results: Screening with inhibitors revealed specific inhibition only with the map kinase (MEK)/extracellular signal regulated kinase (ERK) inhibitor, U0126. Accordingly, fluorescence-activated cell sorting and western blot analysis showed that ERK phosphorylation is induced in the effector cells within 1 hr of incubation with the veto cells. ERK phosphorylation had no effect on the Fas expression level, nor was it reduced when using effector cells from Fas KO mice. Examination of ERK phosphorylation in high and low MHC-I expressing effectors revealed marked differences, suggesting that the interaction between CD8 on the veto CTL, and MHC-I on the effector cells is likely responsible for ERK phosphorylation. Furthermore, XIAP in 2C cells is specifically reduced on binding to the cognate veto cells during the mixed lymphocyte reaction but before the appearance of Annexin V reactivity.

Conclusions: These results suggest that the interaction between CD8 on veto CTL and the MHC class I alpha3 domain on the effector cell, leads to phosphorylation of MEK/ERK in the latter cell, associated with a significant reduction of XIAP levels which, in turn, enables potent triggering of Fas-FasL mediated apoptosis on cognate binding of the veto CTLs.

Download full-text PDF

Source
http://dx.doi.org/10.1097/TP.0b013e3181e86b28DOI Listing

Publication Analysis

Top Keywords

effector cells
24
erk phosphorylation
16
veto cells
12
cells
11
veto
9
cytotoxic lymphocytes
8
mhc class
8
induced effector
8
fluorescence-activated cell
8
cell sorting
8

Similar Publications

The biology centered around the TGF-beta type I receptor Activin Receptor-Like Kinase (ALK)1 (encoded by ACVRL1) has been almost exclusively based on its reported endothelial expression pattern since its first functional characterization more than two decades ago. Here, in efforts to better define the therapeutic context in which to use ALK1 inhibitors, we uncover a population of tumor-associated macrophages (TAMs) that, by virtue of their unanticipated Acvrl1 expression, are effector targets for adjuvant anti-angiogenic immunotherapy in mouse models of metastatic breast cancer. The combinatorial benefit depended on ALK1-mediated modulation of the differentiation potential of bone marrow-derived granulocyte-macrophage progenitors, the release of CD14+ monocytes into circulation, and their eventual extravasation.

View Article and Find Full Text PDF

Purpose Of Review: The purpose of this review is to summarize the current understanding of cell-autonomous innate immune pathways that contribute to bone homeostasis and disease.

Recent Findings: Germ-line encoded pattern recognition receptors (PRRs) are the first line of defense against danger and infections. In the bone microenvironment, PRRs and downstream signaling pathways, that mount immune defense, interface intimately with the core cellular processes in bone cells to alter bone formation and resorption.

View Article and Find Full Text PDF

Atopic dermatitis (AD) is a multifaceted inflammatory skin condition characterized by the involvement of various cell types, such as keratinocytes, macrophages, neutrophils, and mast cells. Research indicates that flavonoids possess anti-inflammatory properties that may be beneficial in the management of AD. However, the investigation of the glycoside forms for anti-AD therapy is limited.

View Article and Find Full Text PDF

Background: Post-coronavirus disease 19 lung fibrosis (PCLF) shares common immunological abnormalities with idiopathic pulmonary fibrosis (IPF), characterized by an unbalanced cytokine profile being associated with the development of lung fibrosis. The aim of the present study was to analyze and compare the different subsets of CD4- and CD8-T cells, along with specific cytokine expression patterns, in peripheral blood (PB) from patients affected by PCLF and IPF and healthy controls (HCs).

Methods: One-hundred patients followed at the Rare Lung Disease Center of Siena University Hospital were enrolled.

View Article and Find Full Text PDF

Background: Multiple myeloma (MM) is an incurable plasma cell malignancy with increasing global incidence. Chimeric antigen receptor (CAR) T-cell therapy targeting BCMA has shown efficacy in relapsed or refractory MM, but it faces resistance due to antigen loss and the tumor microenvironment. Bispecific T-cell engaging (BITE) antibodies also encounter clinical challenges, including short half-lives requiring continuous infusion and potential toxicities.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!